Alambic Investment Management’s Amedisys AMED Stock Holding History

Alambic Investment Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,083	Closed	-$666K	–	285
2019 Q3	$666K	Sell	5,083 -2,080	-29%	-$271K	0.5%	62
2019 Q2	$870K	Sell	7,163 -4,157	-37%	-$493K	0.54%	58
2019 Q1	$1.4M	Sell	11,320 -180	-2%	-$22.6K	0.57%	48
2018 Q4	$1.35M	Buy	11,500 +8,600	+297%	+$1.01M	0.57%	57
2018 Q3	$362K	Sell	2,900 -24,750	-90%	-$2.73M	0.29%	127
2018 Q2	$2.36M	Sell	27,650 -1,300	-4%	-$95.5K	0.65%	42
2018 Q1	$1.75M	Sell	28,950 -19,900	-41%	-$1.13M	0.24%	150
2017 Q4	$2.58M	Buy	48,850 +7,200	+17%	+$379K	0.31%	120
2017 Q3	$2.33M	Buy	+41,650	New	+$2.2M	0.25%	137

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Alambic Investment Management's AMED Position: Q4 2019 in Review

Alambic Investment Management sold out of Amedisys (AMED) in Q4 2019, closing a stake of 5,083 shares — an estimated $666K sold.

Alambic Investment Management first reported a position in AMED in Q3 2017 and held it in 9 quarters. The position peaked at $2.58M in Q4 2017. 325 funds tracked by Wall St. Rank hold AMED as of Q4 2019.

Alambic Investment Management reported no remaining Amedisys position as of Q4 2019 after selling out during the quarter.
Alambic Investment Management sold 5,083 Amedisys shares in Q4 2019, an estimated $666K.
Alambic Investment Management first reported a position in Amedisys in Q3 2017 and held it in 9 quarters.
Alambic Investment Management's Amedisys position peaked at $2.58M in Q4 2017.
325 funds tracked by Wall St. Rank held Amedisys as of Q4 2019.

Based on Alambic Investment Management's 13F filing for Q4 2019, filed 12 Feb 2020.